Growth Hormone Deficiency Market 2022 Estimation and Forecasts up to 2027

 Growth Hormone Deficiency Market

Growth hormone deficiency also called pituitary dwarfism or simply dwarfism, refers to a condition resulting from inadequate quantities of growth hormone in the body. Kids with GHD have weirdly short stature with usual body proportions. According to the MRFR reports, the global market for growth hormone deficiency is projected to acquire a market size of USD 5,243.3 Million by 2027 with a healthy CAGR of 4.20%.

The growth of the GHD market is being driven by the factors such as a rise in growth hormone used to prevent aging, an increase in neuropsychiatric cases, an increase in growth hormone deficiency disorders, and the rise in awareness of the treatment procedure. However, the fluctuations in drug productivity in pharmaceutical companies and the high cost of the treatment may have an adverse impact on the market growth.

Competitive Analysis

The global market for growth hormone deficiency is flooded with a wide number of players spread worldwide. The players in the market are focusing more and more on the implementation of new strategies and policies such as collaborations, expansions, acquisitions, joint ventures, and a rising number of FDA approvals. The list of leading players in the growth hormone deficiency market includes companies such as Pfizer, Merck KGaA, Novartis AG, Eli Lily and Company, Novo Nordisk A/S, and several others.

Segment Analysis

The global Growth Hormone Deficiency Market is divided into several segments based on brand, application, distribution channel, route of administration, and region.

By brand, the market is split into Omnitrope, Saizen, Humatrope, Genotropin, Norditropin, and others.

By application, the growth hormone deficiency market is divided into prader willi syndrome, adult growth hormone deficiency, turner syndrome, small for gestational age, idiopathic short stature, and pediatric growth hormone deficiency.

Based on the route of administration, the market is split into intravenous, intramuscular, and subcutaneous.

The market is split into E-commerce, clinics, retail pharmacies, and hospital pharmacies by distribution channel.

Regional Analysis

The global market for growth hormone deficiency is studied across five major regions: Asia-Pacific, Europe, North America, South America, and the Middle East & Africa.

The North American regional market for growth hormone deficiency held the top position in the global market in 2019 and is likely to maintain dominance over the review timeframe. The growth of the regional market is attributed to the factors such as growing awareness regarding the efficacy of the hormone in short stature, expanding applications of the hormone, and the rising prevalence of growth hormone deficiency. The US and Canada are two major markets in the region.

The European regional market for growth hormone deficiency is likely to exhibit substantial growth over the review timeframe. The region is mainly divided into two major parts, such as Western Europe and Eastern Europe. The Western European region is comprised of Spain, Italy, France, the UK, and Germany. The market is projected to secure the second position in the growth hormone deficiency market over the assessment timeframe. The regional market's growth is being driven by the factors such as growing government expenditure for the healthcare sector, rising shift towards growth hormones in the treatment of Idiopathic Short Stature (ISS), and the increasing occurrences of growth hormone deficiencies.

The Asia-Pacific regional growth hormone deficiency market is projected to record the highest growth rate over the forecasted era. The growing healthcare expenditure is mainly propelling the growth of the regional market. Additionally, the rising investments by market players in the region, given the increasing demand, are also projected to catalyze the regional market's growth.

The Middle East & African regional market is expected to significantly grow over the assessment timeframe due to the growing patient pool, rising investments by major market players, and increasing healthcare expenditure.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013v

Cell Lysis and Disruption Market Shares Analysis, Key Development Strategies and Forecasts Till 2027

 Market Forecast

Registering a CAGR of 8.6%, the Global Cell Lysis & Disruption Market is expected to reach USD 5.7 Billion in by 2025.

 The expanding biotechnology and biopharmaceutical sector are driving the growth of this market. For instance, firms in the U.S. firms perform extensive R&D in pharmaceuticals which is approximately USD 75 billion. 

The market is dominated by numerous established players. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in June 2018, Thermo Fisher Scientific acquired Gatan, Inc. from Roper Technologies for approximately USD 925 million.

Market Influencers

The rising focus on personalized medicine would directly drive the growth of the global cell lysis & disruption market. Strategic initiatives, mergers & acquisitions, partnerships, agreements, product launches, government approvals, and expansion of manufacturing facilities by major competitors are expected to positively affect market growth during the forecast period.  

Key Players

• Bio-Rad Laboratories, Inc. (US)
• Danaher Corporation (US)
• Thermo Fisher Scientific, Inc. (US)
• Miltenyi Biotec (Germany)
• Merck KGAA (Germany)
• Qsonica, LLC (US)
• Becton Dickinson & Company (US)
• Cell Signaling Technology, Inc. (US)
• Hoffmann–La Roche Ltd (Switzerland)
• Qiagen N.V. (Netherlands)

Segmentation

The global Cell Lysis & Disruption Market has been segmented into technique, product, cell type, and end user.

By technique, the market has been segregated into reagent based and physical disruption. The reagent based segment has been further sub-segmented into detergent and enzymatic. The physical disruption further divided into mechanical homogenization, ultrasonic homogenization, pressure homogenization, and temperature treatments

By product, the market has been bifurcated into consumables and instruments. The consumables segment is estimated to hold major market share in the market due to the rise in funding of cell based research. Consumables has been further divided into reagent and kits, beads and disposables. The instrument segment has been further categorized as sonicators, homogenizers, French press, microfluidizer, and others. 

On the basis of cell type, the global cell lysis & disruption market has been classified as mammalian cells, microbial cells, and others.

The global cell lysis & disruption market, by end user, has been divided into research laboratories and institutes, pharmaceutical and biotechnology companies, and others.

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global cell lysis & disruption market owing to the growing clinical R&D budgets by both governments as well as public and private organizations in the pharmaceutical and biotech sector and increasing demand for novel therapeutics in the region.  Additionally, the rising prevalence of geriatric population along with various chronic diseases is contributing to the growth of this market.

According to a report by the Population Reference Bureau, the number of older population (aged 65 and above) will rise to nearly 24% from 15% by 2060. Europe is expected to hold the second-largest position in the global cell lysis & disruption cell lysis buffer market owing to the presence of a strong academic & research base and availability of funding for research in the European countries. Moreover, rising healthcare expenditure is boosting the market in this region. Asia-Pacific is anticipated to be the fastest-growing region is due to the growing interest of major key players in emerging markets and rapidly developing healthcare infrastructure in this region. The Middle East & Africa has the least share of the global cell lysis & disruption market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector. 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013v

Immunoprecipitation Market SWOT Analysis, Major Key Players Revenue, Analysis and Forecasts to 2027

 Market Analysis

The global immunoprecipitation market is predicted to touch USD 562 million at a 5.2% CAGR over the forecast period (2022-2027), states the new Market Research Future (MRFR) report. Immunoprecipitation (IP), simply put, is a technique to precipitate a protein antigen out of a solution utilizing an antibody which specifically binds to that specific protein. The process can be used for isolating and concentrating a specific protein from a sample having thousands of various proteins. The IP technique help researchers in identifying the proteins activation status, determining protein modifications that are post-translational, measuring a given protein’s molecular weight, and capturing protein-binding molecules in both the study of protein-nucleic and protein-protein interactions.

Various factors are propelling the immunoprecipitation market growth. These factors, as per the new MRFR report, include increasing number of research activities in life science, growing need for identifying antigens related to autoimmune diseases, and increasing investments by industries and governments. Additional factors pushing market report include growing awareness regarding personalized therapeutics, rising biotechnology research, a growing number of immunoprecipitation assays to purify and isolate antigens, and repeat purchase of kits.

On the flip side, the availability of alternative protein purification technologies may hamper the immunoprecipitation market growth over the forecast period.

Key Players

Leading players profiled in the immunoprecipitation market report include Geno Technology Inc., Cell Signaling Technology, Inc., Rockland Immunochemicals Inc., Takara Bio Inc., BioLegend, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, and Abcam plc, GenScript. Various strategies have been adopted by key players for capturing the competitive market such as partnerships, collaborations, mergers and acquisitions, research and development activities, and more.

April 2022: EpiCypher has signed an agreement with Thermo Fisher Scientific to offer co-exclusive usage of SNAP ChiP (sample normalization and antibody profiling for chromatin immunoprecipitation) technology that is specific for histone PTMS.

Market Segmentation

The MRFR report provides an all-inclusive segmental analysis of the Immunoprecipitation Market report on the basis of product, type, and end user.

Based on type, the immunoprecipitation market is segmented into RNA immunoprecipitation, chromatin immunoprecipitation, co-immunoprecipitation, and individual immunoprecipitation. Of these, the individual immunoprecipitation segment will have the largest share in the market over the forecast period. The individual immunoprecipitation is widely used to study protein-protein interactions for detecting the presence of antigens and determining its relative quantity that is driving its use in different research studies.

Based on product, the immunoprecipitation market is segmented into reagent, kit, and others. The reagent segment is again segmented into beads and antibodies. Antibodies are again segmented into primary as well as secondary. Beads are again segmented into buffers, magnetic beads, and agarose beads. Of these, the agarose beads segment will dominate the market over the forecast period.

Based on end user, the immunoprecipitation market is segmented into contract research organizations, academic and research institutes, pharmaceutical and biotechnology companies, and others. Of these, the pharmaceutical and biotechnology companies segment will lead the market over the forecast period chiefly due to the growing demand for protein-based drugs.

Regional Analysis

By region, the immunoprecipitation market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific, and the Middle East and Africa. Of these, the Americas will lead the market over the forecast period. Factors aiding growth in the region include the presence of several market players, increasing research activities, and a well-developed healthcare sector in the region.

The immunoprecipitation market in Europe is predicted to have the second-largest share in the market over the forecast period. This is chiefly due to the accessibility of funds for research.

The immunoprecipitation market in the APAC region is predicted to grow at the fastest pace over the forecast period. Factors aiding growth in the region include growing awareness regarding personalized therapeutics, growing biotechnology research in the region, and growing investment from governments.

The immunoprecipitation market in the Middle East and Africa is predicted to have a small share in the market over the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013v

Hemostasis and Tissue Sealing Agents Market Financial Overview, SWOT Analysis, Key Development and Forecasts Till 2027

 Market Highlights

The global hemostasis and tissue sealing agents market is projected to grow at a CAGR of 8.6% over the forecast period. There has been increasing demand for such products as it reduces complication during surgical procedures. Moreover, large number of surgical procedures across the globe are impacting the growth of the market positively. Increasing numbers of surgery procedures worldwide is one of another reason for driving the growth of the hemostasis and tissue sealing agents market.  Surgeries are performed by making cut on the body which leads to the wound formation. Hemostasis and tissue sealing agents products are used in external surgical processes for reducing bleeding. For example, they are used in neurosurgical procedures, cardiac surgery, bariatric surgery, leg surgery, cesarean and orthopedic surgery. Hemostasis and tissue sealing agents products, are frequently used to reduce complexity and reduce recovery time after surgery. The high surgical procedure numbers lead to rising need for hemostasis and tissue sealing agents which reduces the risk during surgical procedures. However, factors such as increasing advancement minimally invasive procedures, lack of reimbursement for these products is hampering the growth of the market.

Key Players

Some of the prominent players in the global hemostasis and tissue sealing agents market are Johnson & Johnson, Cryolife, Inc., Baxter International, Inc, Ethicon LLC, Integra Lifesciences Corporation, Becton, Dickinson & Company, Cohera Medical, Inc., Pfizer, Inc, Medtronic plc, B. Braun Melsungen AG, MIL Laboratories Pvt. Ltd, Advanced Medical Solutions Group Plc and others.

Segmentation

The global hemostasis and tissue sealing agents market has been segmented into product, and end user.

By product, the market has been segmented into topical hemostats, and adhesive & tissue sealant. Furthermore, topical hemostats is divided into Active, mechanical (collagen based hemostats, cellulose based hemostats, gelatin based hemostats, polysaccharide based hemostats) Flowable. Adhesive & tissue sealant is further segmented into synthetic, natural, and adhesion barrier.

Further on the basis of end user the market is bifurcated into hospitals, ambulatory centers and others

Regional Analysis

Geographically, the Americas is anticipated to dominate the global hemostatic agent market owing to the high clinical R&D budgets by both government as well as public and private organizations, presence of major manufacturers for the products, high number of surgical procedures and various others. For instance, according to the Center for Diseases Control and Prevention, approximately 46.5 million surgical procedures are performed every year in the U.S.

Europe is expected to hold the second largest position in the global hemostasis and tissue sealing agents market. The Hemostasis and tissue sealing agents market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increased medical tourism for surgical procedures, increasing healthcare expenditure in developing countries and various others. The Middle East & Africa has the lowest share of the global hemostasis and tissue sealing agents market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013v

Assisted Reproductive Technology Market Solid Segment Analyzed by Latest Trends, Growth Rate and 2027 Insight

 Market Highlights

The assisted reproductive technology (ART) market is expected to witness tremendous growth owing to the rising prevalence of infertility in males as well as females. Other key factors such as the growing obesity among population, rising ovulation disorders, change to sedentary lifestyle, socioeconomic factors like postponement of marriage due to unemployment and others, growing consumption of unhealthy diet, increasing occurrence of polycystic ovarian syndrome (PCOS), and increasing prevalence of breast or ovarian and endometrial cancer, increase in smoking and alcohol consumption are contributing towards the growth. 

However, factors such as, lower success rate, the high cost of artificial reproductive technology procedures, expensive treatments, raising ethical issues, chances of birth defects, the risk of prematurity and low birth weight in new-borns and side effects associated with hysterectomy procedures are expected to restrict the market growth during the forecast period.

Key Players

Some of the key players in the global assisted reproductive technology (ART) market are Cosmos Biomedical Limited, California Cryobank, Bloom IVF Centre, Cryolab Ltd., Parallabs, OvaScience, Anecova, Origio, Microm Ltd., Merck KGaA, Cooper Surgical, Inc, Ferring Pharmaceuticals, European Sperm Bank, Irvine Scientific and Hamilton Throne Ltd.

Segmentation

The global Assisted Reproductive Technology Market is segmented on the basis of diagnosis, type, and end-user. The assisted reproductive technology market, by diagnosis, is categorized into ovulation testing, hysterosalpingography, ovarian reserve testing, genetic testing, other hormone testing and imaging tests. On the basis of type, the market is segmented into Ovulation Induction (OI), Artificial Insemination (AI), Donor Conception, In-Vitro Fertilization (IVF), Gamete Intrafallopian Transfer (GIFT), Intracytoplasmic Sperm Injection (ICSI), Preimplantation Genetic Diagnosis (PGD) and Surrogacy. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers, and IVF Centers and others

Regional Analysis

Europe (UK, Belgium, France, and Netherlands) is the largest in the market owing to the increasing prevalence of obesity and growing healthcare expenditure. As per the World Health Organization, 23% of the women in Europe were obese in 2014.

The Americas is the second largest the assisted reproductive technology (ART) market during the forecast period. The increasing occurrence of ovarian cancer drives the market in this region. The American Cancer Society estimated that in 2018, 22,240 women are likely to be diagnosed with ovarian cancer. This is expected to influence the market growth during the forecast period. 

Asia-Pacific was projected to be the fastest growing region for the global assisted reproductive technology (ART) market in 2017. The market is expected to witness growth owing to the rising prevalence of diabetes in women, changing lifestyle, and growing obesity within the female population. According to the Virtus Health 2018, infertility affects one in six Australian couples of the reproductive age. This is expected to provide favorable backgrounds for the market to grow.

The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013v

Clinical Decision Support Systems Market Value Chain, Factor Analysis, Region and Forecasts Till 2027

 Market Overview:

With a 12 percent CAGR, the Clinical Decision Support Systems (CDSS) market is estimated to reach USD 1.76 billion by 2023. Clinical decision support systems (CDSS) are an essential component of the healthcare IT spectrum. Breakthrough technological developments encourage CDSS adoption, which enables speedier decision-making, data management, and enhanced workflow competency in inpatient care. The adjustable functions of this system are playing a significant role in boosting Clinical Decision Support Systems Market trends. The COVID-19 epidemic has created new hurdles in the healthcare ecosystem. Hospitals and health systems are dealing with massive influxes of critically sick patients as well as personnel shortages and capacity constraints.

However, doctors are now better equipped with the information and abilities gained during the pandemic's early stages to develop the ideas. The increased usage of clinical decision support software in COVID-19 has emphasized the global need for comparable healthcare data while shortening the duration of decision-making owing to unprecedented stress. Many health care providers have changed their clinical decision support system vendors to promptly communicate desired outcomes. As a result, many of the world's major healthcare facilities, which are among the first responders, have a greater understanding of the usefulness and challenges of clinical decision support systems to discover new ideas for the company and for the future market. As a result, there is a need for clinical decision assistance in forms that make pertinent data easily accessible. Workflow integration is expected to emphasize market expansion in the future.

Competitive Landscape

Some of the key players in the global clinical decision support system are Meditech, Cerner Corporation, Carestream, Elsevier B.V., Wolters Kluwer Health, Agfa-Gevaert Group, Athenahealth, Inc, Epic Systems Corporation, Allscripts, Hearst health and others.

Market Segmentation:

It is expected that the software segment will grow rapidly.

By Product: During the projection period, the integrated variant category is expected to gain traction.

By knowledge: The knowledge-based CDSS is expected to acquire market share as a result of increased efficiency in fast-paced workplaces. The cloud sector has more potential since it provides more scalability throughout the predicted period.

Regional Classification:

Because of the region's cutting-edge healthcare computerised decision support system industry, North American clinical decision support businesses are expected to lead the worldwide market. The technical advancement in the healthcare industry in North America has been consistent due to the presence of several key firms in the region, resulting in access to various progressive models of clinical decision support systems. The region's rising healthcare expenditure is expected to drive the clinical decision support systems market in the future.

Industry News:

The clinical decision support systems market is dominated by some competitors worldwide. The Americas is a significant company's center, earning maximum market share and transforming this area into a well-established market. These firms have also extended their operational units to other locations. Furthermore, additional small and medium-sized firms profit from the local market. Wolters Kluwer Health, Allscripts, Meditech, Athenahealth, Inc, Cerner Corporation, Elsevier B.V., Hearst Health, Carestream, Epic Systems Corporation, and Agfa-Gevaert Group are important competitors in the worldwide clinical decision support system market. In 2017, the top four businesses were Meditech, Cerner Corporation, Epic Systems Corporation, and Allscripts, which accounted for almost 60% of the overall clinical decision support systems market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013v

Blood Glucose Monitoring Market SWOT Analysis, Major Key Players Revenue, Analysis and Forecasts to 2027

 Blood Glucose Monitoring Market Overview:

A healthy body stays healthy due to all kinds of enzymes in the body being in proper balance. Excess of an enzyme can disturb balance while deficiency of another one can have the same effect. People who are suffering from genetic ailments like diabetes are more prone to such problems. Therefore, monitoring things like glucose in the blood is necessary for such people, and this is the reason for the global blood glucose monitoring market to take shape and grow. Blood glucose monitoring helps to recognize the glucose level of blood within the specified target range. The devices facilitating this monitoring provide useful insight to manage diabetes. These insights help to track the progress of treatment goal and observe the effect of medication on blood sugar level and understand how the ailment affects glucose level in blood.

Market Research Future (MRFR) has published a research report about the global blood glucose monitoring market that predicts the market growth with 7.1 % CAGR (Compound Annual Growth Rate) between 2017 and 2023. Devices known as blood glucose meter are designed to apply to the different type of diabetes. According to this report, the market for these devices is growing due to developing technology for monitoring and diagnosis of diabetes, early detection of diabetes, increasing demand for continuous glucose monitoring devices, and increasing prevalence of diabetes.

Key Players

The key players in the global blood glucose monitoring market include Abbott Laboratories (USA), Arkay, Inc. (the USA), Bayer Healthcare AG (Germany), Dexcom, Inc. (the USA), GlySure Ltd (UK), Goldsite Diagnostics Inc. (China), F. Hoffmann-La Roche Ltd (Switzerland), LifeScan, Inc. (the USA), and Sphere Medical Holding PLC (UK).

Segmentations:

In this report, the global Blood Glucose Monitoring Market has been segmented on the basis of application, end user, product type, and lastly, region. On the basis of application, this market has been segmented into type 1 diabetes, type 2 diabetes, gestational diabetes, and others. The first two types of diabetes harm the body in the same way. The difference between the first two types of diabetes is regarding insulin. Patients suffering from type 1 diabetes do not produce insulin. On the other hand, patients with type 2 diabetes do not respond to insulin as well as they should and later in the disease often do not make enough insulin. Their body produces a little bit of insulin but fails to use it effectively. Gestational diabetes only happens during pregnancy. The patient gets high blood sugar levels during pregnancy, despite their levels being normal before pregnancy.

On the basis of product type, the market has been segmented into continuous glucose monitoring (CGM), invasive glucose monitoring (IGM), and flash glucose monitoring. CGM is defined as an advanced way for people living with diabetes to check glucose readings in real-time or monitor them over a period of time. IGM refers to the measurement of blood glucose levels (required by people with diabetes to prevent both acute and chronic complications from the disease) by taking their blood sample. Flash Glucose Monitoring is a small sensor that diabetes patient wears on the skin. This sensor stores the user's blood glucose (or blood sugar) levels continuously. The user can access them by scanning the sensor at his/her ease. Based on end users, the market has been segmented into clinics, diagnostic centers, home care diagnostics, hospitals, and research centers.

Regional Analysis:

The regional segmentation of global Blood Glucose Monitoring Market Growth segments the market into regions namely The Americas (North America & South America), Europe, Asia Pacific, and Middle East & Africa (MEA). The Americas command the largest market share due to the notable increasing incidence of obesity, physical inactivity, and unhealthy diet. With medical facilities being more advanced in North America, it is a bigger market than South America. In North America, the biggest markets comprise of the United States of America (USA) and Canada. Many key players in this market are based in the USA.

Due to reasons same as The Americas, in Europe, Western Europe is greater market than Eastern Europe. Europe is the second largest market for blood glucose monitoring, followed by the Asia Pacific in the global blood glucose monitoring market, owing to the environmental pollutants, psychosocial factors, smoking, and socioeconomic deprivation. Furthermore, government support via for research & development (R & D) regarding blood glucose monitoring boosts this market. The biggest markets in Europe, include France, Germany, Italy, Spain, and the United Kingdom (UK), followed by the rest of Europe.

In the Asia Pacific region, the market is growing rapidly due to high population and increasing number of diabetes patients. In this region, people are not as health conscious as they are in North America and Europe. Due to increasing demand for new treatment methods in countries like India and South Korea, Asia Pacific is likely to emerge as the fastest growing market across the globe during the forecast period. Apart from India and South Korea, the biggest markets in this region include Australia and Japan, followed by the rest of Asia Pacific.

In the MEA region, the market is small and limited due to little investment in healthcare and lack of awareness about health problems. In this region, the biggest market comprises of Kuwait, Oman

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013v

Cosmetic Surgery Market Trend, Industry Overview, Competitive Analysis and Foreseen by 2027

 Market Overview

A CAGR of 7.8 per cent is expected for the forecast period between 2022 and 2027, bringing the total global cosmetic surgery market to USD 21.97 billion. Plastic surgery is a subcategory of surgery for those who want to enhance their appearance via cosmetic procedures. There is a growing demand for cosmetic surgery due to improved safety margins, overweight, mishaps, and the growth of cosmetic surgery facilities.

Cosmetic surgery has a growing safety margin and a rising prevalence of cosmetic surgery facilities, among other things, all of which impact people's health. Innovative materials, like silicone implants, are one example of a technological component. The global cosmetic surgery market is being driven by increased income levels, decreased plastic surgery prices, etc.

The cosmetic surgery business is predicted to grow at a much slower rate in 2020 because of the COVID-19 epidemic. A steady rise is expected to continue during this forecast period. Zoom calls have become more commonplace due to employees doing more of their work while away from their desks. People are more self-conscious than ever before about their appearance. Because of this, there has been a rise in demand for cosmetic operations such as Botox. Interest in non-invasive operations has grown in the last several months, but interest in more intrusive procedures has decreased.

Competitive Landscape:

Notable players profiled in the report of the cosmetic surgery market are Valeant Pharmaceuticals International, Cutera, Inc., Johnson & Johnson, Syneron Medical Ltd., Genesis Biosystems, Inc. Allergan, Inc., and others.

Market Segmentation

According to the research findings, the worldwide cosmetic surgery market can be broken down into segments based on the various kinds of procedures and geographic locations.

In 2021, the non-invasive procedures category accounted for more than 54.0 per cent of the market's sales. In the next years, this market category is expected to grow quickly, ensuring its hegemony over the whole market. Non-invasive treatments are becoming popular because of their convenience, speed, and cheap cost. Chemical peels, Botox injections, and soft tissue fillers are well-known non-invasive cosmetic treatments.

Regional Classification

North America accounts for the majority of sales. The market in the area is expected to increase gradually over the next several years. Cosmetic surgery is becoming more widely accepted, and people are becoming more aware of it, a major factor in the industry's growth. In addition, the region's cosmetic surgery suppliers business is benefiting from considerable advancements in allied technology, such as enhanced silicone and polymer implants.

The cosmetic surgery market is very competitive worldwide, with the European region holding the second-largest share. Cosmetic surgery market expansion in the area is fueled by an improved economy and a rise in the number of patients. In addition, increasing levels of knowledge and developments in medical advances are having a positive impact on the expansion of the cosmetic surgery sector in this area.

Industry News

GC Aesthetics, Inc. will introduce a new line of breast implants called PERLE in May 2021. With its patented surface technology, GCA's leading gel integration, and updated preventive measures that have supported GCA's long-term great safety record, PERL is an extremely creative range of seamless breast implants.

The FDA authorised Defyne for the augmentation and repair of mild to severe chin retrusion in people over 21 in February 2021, Galderma stated.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013v

Medical Devices Market Outlook, Key Financials, Segmental Revenue and Geographical Revenue till 2027

 Key Players:

GE Healthcare (US), Fresenius (Germany), Medtronic (Ireland), Johnson & Johnson (US), Stryker (US), Siemens (Germany), Abiomed Inc. (US), Abbott Laboratories (US), Boston Scientific Corp. (US), Accuray Inc. (US), Bio Rad Laboratories Inc. (US), Becton Dickinson (US), Biotelemetry Inc. (US), Baxter International Inc. (US), and Angiodynamics Inc. (US) are some reputed key players functioning in the worldwide medical devices market.

Medical Devices Market Highlights:

Market Research Future (MRFR), in its “Medical Devices Market” report, states that the market can value at USD 6170.72 Bn at 22% CAGR by 2030. In 2018, the global medical devices market was recorded at about USD 1533.97 Bn. The surge in the medical device market is likely, due to an increase in the need for medical devices. Global Medical Devices Market are used to diagnose, prevent, and the prognosis of diseases. The growing utility of medical devices is expected to prompt the expansion of the global market. The availability of different types of medical devices from surgical equipment to wheelchairs can impel the expansion of the global medical devices market. Other driving factors of the worldwide medical devices market are an increase in patient pool afflicted with various malaises, the surge in cases of accidents, and hefty investment on R&D to develop effective medical solutions. The intervention of disruptive technology in the research and development field of the healthcare industry can bolster the expansion of the medical devices market growth. In addition, the growing prevalence of cardiac problems and the expansion of the geriatric populace promoting the need for medical devices can encourage their market growth. On the downside, expensive medical devices and other healthcare expenses can resist the growth of the medical devices market.

Segmental Outline:

The Global Medical Devices Testing Services was studied based on Therapeutic Application, Product Type, and End Users.

By product type, the market segments are diagnostic devices, monitoring devices, surgical devices, drug delivery devices, treatment equipment, bio-implants and stimulation devices, and others. The monitoring devices segment comprises of neuromonitoring devices, cardiac monitoring devices, multi-parameter monitoring devices, respiratory monitoring devices, fetal and neonatal monitoring devices, hemodynamic monitoring devices, temperature monitoring devices, and weight monitoring devices. The diagnostic devices comprise imaging devices, endoscopes, surgical ENT devices, and others. The expansion of the medical devices market can be attributed to the expansion of the diagnostic devices segment.

By therapeutic application, the market segments are general surgery, gastrointestinal surgery, respiratory, diagnostic imaging, orthopedics, dental, cardiovascular, ophthalmology, neurology, nephrology, ear-nose-throat (ENT), and urology, and others. The increase in the population of chronic patients can prompt the expansion of the global medical devices market.

By the end-user, the medical devices market segments are diagnostic centers, hospitals & clinics, pharmaceutical companies, and research laboratories.

Regional Outline:

The worldwide medical devices market’s regional segments are Europe, the Americas, Asia Pacific, and the MEA. North America's medical devices market to lead in the global market. The regional market poised to value at a decent amount. Europe's medical device market is can touch a considerable valuation on the conclusion of the review period. Asia Pacific medical device market can thrive at a healthy CAGR across the assessment period. Japan and China are deploying advanced technologies for seamless operation of medical devices. The high concentration of reputed medical devices developers in Europe and North America and high export trading activities concerning medicine-centric gadgets can bolster the expansion of the medical devices market in these regions.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013v

Microfluidics Device Market Top 10 Players Universal Analysis, Industry Demand and 2027 Forecast

 Microfluidics Device Market – Competitive Analysis

Highly competitive, the microfluidics market appears to be fragmented owing to the presence of several large and small-scale players. These players invest substantially in R&D to develop advanced sensors. High potential growth opportunities that the market demonstrates are in turn, attracting several new entrants to the Microfluidics Companies market, further intensifying the competition in the already fiercely competitive market.

Well-established players incorporate strategic initiatives such as acquisition, collaboration, expansion, partnership, and product & technology launch in order to gain a competitive advantage in this market and to maintain their market positions.

Prominent manufacturers of microfluidics invest substantially in technology and R&D activities and most of all, in acquiring other promising firms in the rapidly growing regions to meet their expansion plan. The rising government fundings are motivating key companies to manufacture new devices that can match the changing trends and needs of the customers.

Microfluidics Device Market Overview:

The microfluidics devices market is growing continually due to the vital role these devices play in the integration, miniaturization, and parallelization of various tests in the fields of diagnostics, drug development, and biological research. Moreover, widely accepted microfluidic technology that has several applications is escalating the market on the global platform, allowing integration of many medical tests on a single chip.

Acknowledging the phenomenal accruals, the market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the global microfluidic device market will touch a phenomenal valuation by 2027, registering a strong CAGR throughout the forecast period (2022-2027).

The increasing prevalence of chronic diseases such as heart-related diseases and as cancer is prompting the demand for new drugs. Owing to their efficacy, microfluidics devices are increasingly becoming popular and are garnering tremendous traction across the life science and pharmaceutical sector.

As a result, the microfluidic device market is increasing over the past couple of years, accounting for a significant market share, worldwide. Large advancements in technology and the vast uptake of these advanced technologies drive the growth of the microfluidics device market on the global platform.

Additional factors propelling the market growth include the significant increase in the pharma sector and the increasing prevalence of chronic and lifestyle-related diseases that require routine vital statistics analysis, fueling the demand for microfluidics devices.

Also, the rise in the commercial and analytical application of these devices and use of microfluidic products for miniaturization of the chip are some of the factors that are driving the growth of the microfluidic devices market.

On the flip side, factors such as the stringent regulatory requirements to decelerate growth and geometrical and surface chemistry issues are obstructing the growth of the market. Nevertheless, factors such as the growing R&D investment in life sciences, pharmaceuticals, increase in the demand and uptake of the point of care testing, as an effective method for delivery of treatment, are expected to support the market growth during the forecast period.

Major Players:

Key players leading the global Microfluidic Device Market include Abbott Laboratories, Siemens Healthcare GMBH, F Hoffmann-La Roche AG, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc, Fluidigm Corporation, Dolomite Centre, Raindance Technologies, Inc., Cepheid, Micronit Microfluidics, Johnson & Johnson, and Becton, Dickinson & Company among others.

Microfluidics Device Market – Segments

For enhanced understanding, the report has been segmented into four key dynamics.

By Application   : Pharmaceutical, Drug Delivery, Analytical Device, Life Science Research, Environmental & Industrial, and others.

By Industry                         : Microfluidics and Microfluidic Devices, among others.

By Material                         : Glass, Polymer, and Silicon.

By Regions                          : North America, Asia Pacific, Europe, and the Rest-of-the-World.

Microfluidics Device Market – Regional Analysis

The North American region, heading with its one of the world's best medical facilities accounts for the leading position in the global microfluidics devices market followed by the European and Asia Pacific region, respectively.  The US, backed by the huge technological advancements and high per capita healthcare expenditures leads the microfluidics devices market in North America.

Undoubtedly, the availability of technologically advanced medical devices is positively impacting market growth.  Furthermore, the presence of well-established healthcare infrastructure and skilled professionals is pushing up the regional market. 

The European region owns the next largest share in the global microfluidic device market, following the North American market closely.  Factors propelling the growth of the regional market include the resurging economy that is availing the best possible healthcare & substantially high healthcare expenditures and the government support that encourages manufacturers of microfluidics devices to develop new and better devices.

The Asia Pacific region is emerging as a profitable market for microfluidics devices due to the rapidly improving healthcare infrastructure. Moreover, factors such as the ever-increasing population that is continually dictating the demand for quality healthcare and the spreading awareness towards the availability and benefits of these devices are positively impacting the growth in the regional market. Rapidly developing economies are expected to provide immense opportunities for the growth of microfluidics devices.

Also, the increasing adoption of technologies is positively impacting market growth in the region. Furthermore, rising healthcare concerns are leading to increasing the market size of the microfluidic device market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013v

Point of Care Diagnostics/Testing Market Forecasts by Industry Drivers, Regions Till 2027

 Point of Care Diagnostics/Testing Market-Overview

The demand for self-diagnosing kits and devices has amplified as the number of coronavirus cases has improved around the world. The ability to streamline the testing procedure for healthcare staff while still delivering accurate results will be critical to the market's overall success. As per MRFR reports, the market is projected to gain USD 36,740.3 million at a CAGR of 11.6% by 2027.

The development of portable POC devices, supporting government policies will supplement the POC diagnostics/testing market. With an increasing number of chronic conditions such as diabetes worldwide and a limited number of healthcare facilities in developing nations in the forecast period, the market will see further traction.

Key Players:

The notable point of care diagnostics companies in the point of care diagnostics/testing market are Siemens Healthineers GmbH (Germany), Chembio Diagnostics, Inc. (US), Trinity Biotech (Ireland), Hoffmann-La Roche Ltd (Switzerland), Becton, Dickinson, and Company (US), Danaher Corporation (US), Abbott Laboratories (US), PTS Diagnostics (US), Nova Biomedical (US), QuidelCorporation (US), Johnson & Johnson Services, Inc. (US), Sekisui Diagnostics (US), Instrumentation Laboratory Company (Werfen) (US) and EKF Diagnostics Holdings plc (UK).

Segmental Analysis

Hospitals & clinics, homecare/self-testing, and diagnostics centers are included in the end users segment in the global point of care diagnostics/testing market. The global point of care diagnostics/testing market has been divided into two categories based on the mode of purchase: prescription-based testing products and over-the-counter (OTC) testing goods. The market has been divided into pregnancy & fertility testing, infectious disease testing, glucose monitoring, drug abuse testing, cardiometabolic monitoring, hematology testing, coagulation monitoring, urinalysis testing, cholesterol, and cancer/tumor marker testing categories based on the product category. The global point of care diagnostics/testing market has been divided into molecular diagnostics, dipstick, and immunoassays based on the platform.

Competitive Analysis

The Point of Care Diagnostics/Testing Market is more inclined to conduct business transactions online than in physical locations. End-users in the business are predicted to exhibit a wide range of preferences in the coming years. The minimization of supply chain bottlenecks is the main objective that market challengers are intended to address aggressively in the predicted year. During the forecast period, the market is anticipated to offer new and profitable expansion options. The battle for the majority share is predicted to change the market landscape in the forecast period fundamentally. After the decline seen in the aftermath of the pandemic, the government bodies of various nations are believed to play an important role in the worldwide market's resuscitation. Companies now have a new mission surrounding the customer journey and the rapid acceleration of digitalization due to the global pandemic. However, the upheaval produced by the COVID crisis has not only created a whole new dimension of risk. Still, it has also prompted enterprises to reassess risks as they navigate cautiously through an uncertain economic climate.

Industry Updates:

Nov 2021 Meridian Bioscience, Inc., a leading global manufacturer of diagnostic testing solutions and life science raw materials, launched its Air-DryableTM LAMP Mix and Air-DryableTM RT-LAMP 1-Step Mix. These ground-breaking molecular master mixes are specifically intended for quick isothermal amplification of nucleic acid sequences to aid in creating ambient temperature-stable point-of-care diagnostics and speed up diagnosis.

Detailed Regional Analysis 

The acquisition of market players by healthcare behemoths, increasing number of market competitors across the region, and supporting government regulations, will contribute to North America holding the greatest point of care diagnostics/testing market share in the forecast period. In order to extend their product availability across the region, healthcare product providers are merging and acquiring current market participants. Due to the limited availability of healthcare workers, changing demographics, diverse manufacturing facilities, and increasing consumer healthcare prospects, the Asia-Pacific point of care diagnostics/testing market is estimated to witness the fastest regional market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013v

Influenza Vaccines Market SWOT Analysis, Major Key Players Revenue, Analysis and Forecasts to 2027

 Market Overview:

The influenza vaccines market is expected to grow at a 6.53 percent CAGR by 2025, reaching USD 7,828.3 million. Humans are vulnerable to the influenza virus, a highly contagious and lethal virus that can infect their respiratory systems. Influenza is a viral respiratory infection that affects the lungs, nose, and throat. People who are chronically unwell or have weakened immune systems are most vulnerable. A viral illness that causes nasal and pulmonary leakage spreads from person to person. Vaccines help to prevent illnesses by boosting the body's natural defenses. Vaccines stimulate the body's creation of antibodies that help it fight illnesses. Most diseases are protected against by vaccination for several years, decades, or even a lifetime. Vaccinations are the most effective way to keep influenza viruses from infecting humans. It is predicted that the influenza vaccine market would reach $6.20 billion by 2026.

The influenza vaccine market is expected to reach $3.96 billion in 2018, with an annual growth rate of 5.9 percent (CAGR) from 2019 to 2026. Between 2019 and 2020, the Centers for Disease Control and Prevention recorded over 13 million documented flu cases. Depending on the current market scenario for influenza vaccinations, government agencies, the Centers for Disease Control and the World Health Organization suggest a licensed seasonal vaccine. Big pharmaceutical companies and organizations are always working to improve the effectiveness of vaccinations against various diseases caused by influenza, which has, in the past, resulted in deaths and turn, led to an upsurge in the influenza vaccine market value.

Industry News:

Profit, sales, and market income are all sources of revenue for market players. The following businesses dominate the influenza vaccines market: GlaxoSmithKline PLC (UK), Abbott Laboratories (US), Seqirus (UK), Mylan NV (US), AstraZeneca (UK), Hualan Biological Engineering Inc. (China), Mitsubishi Tanabe Pharma (Japan), and Serum Institute of India Pvt. Ltd. (India).

Market Segmentation:

By End-Users: They are divided into two primary types. The recombinant influenza vaccine, for example, is available for the elderly and adults. The alternative option is a trivalent vaccination, which is available for children aged 6 months and up

By application: The worldwide influenza vaccine varies depending on numerous aspects and the end goal. Users Individuals from academic institutes, hospitals, clinics, organizations, researchers, and others may be end-users of influenza vaccines in India vaccinations. The research industry is expected to grow throughout the anticipated period. It is driven by the virus's dynamic and changing nature, which mutates every year, and as a result, vaccinations need to be revised every six to twelve months.

Regional Classification:

The influenza vaccine market is divided into four regions: Europe, America, the Middle East, Africa, and Asia-Pacific. America, with a population of more than half a billion people, is leading the influenza vaccination industry. Every year, the influenza virus affects 5% to 20% of the whole population. European markets were the second-largest market for influenza vaccinations throughout the assessment period. The widespread nature of influenza, along with rising product demand, has fueled expansion in the regional market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013v

Vitamin K2 Market Key Developments Trends, Analysis and Forecasts Till 2027

 Market Overview

The global Vitamin K2 market is expected to develop at a CAGR of 7.1 percent (2021-2028). Factors such as rising demand for healthy foods and supplements, rising cases of cardiovascular disease and osteoporosis, and a rise in the global elderly population base will all contribute to the growth.

Vitamin K is a fat-soluble vitamin that aids in the coagulation of blood. Vitamin K is necessary for bone health and the prevention of osteoporosis. Vitamin K (K0) and Vitamin K (K1) are the two subtypes (K). Although their attributes differ depending on the type, both types have synthetic forms. Phylloquinone (K) and menaquinone (M) are the most relevant variations in this context (MK-n).

Market Segmentation

Based on Type, the market is segmented into MK-4, MK-7, Other.

MK-7:

MK-seven is a vitamin K subtype. Menaquinone (shortened MK-n or MenaQ) is another name (the q means quinine). This is required for the production of prothrombin within the body. Since vitamin K is involved in blood clotting, a vitamin K shortage can induce bleeding difficulties.

MK-4:

MK-4 is a kind of Vitamin K that is found in animal tissues naturally. This is sold as a dietary supplement to treat osteoporosis, diabetes-related eye problems, vitamin D deficiency, bone fractures, and age-related macular degeneration (AMD).

The market is divided into Powder and Oil segments based on application.

Powder:

Vitamin K is a powdered vitamin that is used to treat excessive calcium levels. The vitamin assists your body to absorb less calcium, which might minimize your risk of developing osteoporosis or kidney stones. Vitamin K is also used to stop and slow bleeding caused by blood-thinning drugs (anticoagulants) like warfarin.

Oil:

Vitamin K is mostly available in supplements. However, it can also be found in dietary oils for cooking. Plants that produce vitamin K oil are produced on terrain that is rich in particular minerals and nutrients. Plants can create more vitamins within that type of soil than they could if they were growing in a nutrient-deficient condition.

Regional Classification

North America is the greatest market shareholder in 2019, followed by Europe and the Asia Pacific. Within the next 5 years, the demand for vitamin K2 in the Asia Pacific is projected to increase due to a significant increase in the consumption of functional foods by inhabitants of Australia, India, and China. Because of the government's ongoing health and wellness efforts, the Middle East and Africa are likely to have a moderate demand for vitamin K2.

Industry News

The function of vitamin k2 dosage in general health and their benefits on the human body, particularly bones, is well supported by clinical research. Vitamin k-based goods, such as injection form (pharmaceutical grade), food fortification, oral supplements, and dietary supplements, will benefit from this aspect. Because of the rising demand for vitamin supplements, the worldwide Vitamin K market is likely to rise significantly over the forecast period.

Vitamin K injections, which are more expensive than other kinds of vitamin supplementation, could manage vitamin K deficiency. Over the projected period, this aspect will restrain the growth of the Vitamin K injection market. The market for vitamin K, on the other hand, is predicted to rise due to the rising demand for organic foods, which encompasses dairy products.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Cancer Registry Software Market Solid Segment Analyzed by Latest Trends, Growth Rate and 2027 Insight

 Market Insights

Cancer registry software is a programmed tool of a directory that creates and maintains end-to-end reporting of cancer incidences. It is majorly used to get an overview of certain cases while investigating cancer and its causes. According to Market Research Future, the global cancer registry software market reached $56.4 Million in 2022 and is predicted to attain a CAGR of 10.7% during the forecast period, 2022-2027

Extraordinary breakthroughs and penetrations of science and technology are evolving radically and restructuring the practice of medicine. Aging population, growing middle spending abilities on healthcare, the burden of chronic disease is transforming the patient needs. However, these factors are stimulating new demands dedicated to innovation and access to advanced tools that deliver reliable patient data and comprehensive report of every stage in treatment.

Novel technologies such as predictive modeling for medical procedures are set to flourish owing to growing investment in R&D activities in the field of clinical and molecular data. Growing trend of using data analytics to create reference case study for futuristic clinical operations is likely to propel the global cancer registry software market.

Major Players

Industry leaders are keenly focusing on the development of convenient and accessible solutions for handling critical data related to cancer. Some of the leading players contributing with their product and services include McKesson Corporation, Electronic Registry Systems, Inc., IBM, C/Net Solutions, Himagine Solutions Inc, Rocky Mountain Cancer Data Systems, Ordinal Data Inc, Conduent Inc, Elekta AB (PUB), and Onco, Inc.

Market Segmentation

The global Cancer Registry Software Market is broadly segmented based on the factor such as type, deployment model, database, functionality, and end-user.

The type segment is bifurcated into standalone software and integrated software.

Based on the deployment model, the global cancer registry software market is divided into on-premise and cloud-based.

Similarly, the database type segment is classified into public and commercial.

On the basis of functionality, the global cancer registry software market is segmented into product outcome evaluation, patient care management, medical research, clinical studies, and reporting to federal regulations.

Moreover, the end-user segment is diversified into hospitals, government organizations, medical practitioners, pharmaceutical, research centers, medical device companies, and biotechnology.

Regional Analysis

Geographically, the Americas is expected to influence the global cancer registry software market owing to the growing focus on high-tech product development, growing investment for R&D in region.  As per National Cancer Institute, approximately 1,735,350 new cases of cancer were registered in the US, in 2022.

Europe ranks second after the Americas owing to funding availability and existence of robust research and academic institutes in the region. The European cancer registry software market is anticipated to register a considerable growth during the forecast period.

Moreover, emerging pharmaceutical industry due to low manpower cost and favorable trade conditions in developing markets such as India and China are foreseen to speed up the growth of cancer registry software market in Asia Pacific. A growing number of cancer patients in these regions in contrast to the escalating population makes it mandatory to keep a track on every cancer patient and their diagnostic data.

The Middle East & Africa has the least contribution in the global cancer registry software market and is anticipated to see a moderate growth owing to rising government initiatives for healthcare sectors.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Automated Hospital Beds Market SWOT Analysis, Major Key Players Revenue, Analysis and Forecasts to 2027

 Automated Hospital Beds Market Overview

The global automated hospital beds market is reported to grow at a steady and decent pace as per the recently released report by Market Research Future (MRFR). The market is expected to jump from its 2022 valuation of USD 1,590.1 million to reach a valuation of 2,553.4 million by 2027. The global market is expected to grow at a compound annual growth rate of 5.97% during the forecast period between 2022 and 2027.

Patients in hospitals experience difficulty in getting in and out of their assigned beds due to their condition or health status. Automated hospital beds play a significant role in solving this major problem. These automated beds aid patients to easily sit and get out of their beds with comfort and little to no effort. Add to this, the beds are extremely beneficial for both the doctors and the nurses while performing vital treatments or procedures upon the patients. The global market is influenced by a rising number of chronic and acute illness, increasing obese population, growing geriatric population, rising healthcare expenditure, and constantly developing design and technology of hospital beds. However, the high cost associated with such beds can hamper its global market growth during the forecast period.

Competitive Landscape

The global automated hospital beds market comprises a number of prominent players who strive to ensure optimal patient satisfaction and develop new technologies to help the market grow further. Some of the major players identified in the market are Medline Industries, Inc., ArjoHuntleigh, Linet spol. s r.o., Gendron Inc., Hill-Rom, Paramount Bed Holdings Co., Ltd., Invacare Corporation, Stryker, and others.

December 10th, 2022, Hill-Rom, a leading provider of medical technologies specializing in developing hospital beds, announced in a statement about its plans of adopting EarlySense’s contact free monitor into its smart hospital bed, Centrella.

Market Segmentation

The global Automated Hospital Beds Market segmentation is based in terms of type, type of treatment, technology, usage, and end-user.

By type, the market divides into semi-automatic and fully-automatic hospital beds.

By technology, the market segments into smart automated and basic automated hospital beds.

By type of treatment, the market includes acute care, critical care, and long-term care.

By usage, the market comprises of delivery/birthing, general purpose, pediatric, intensive care, psychiatric care, bariatric, pressure relief, and others.

By end-user, the market includes reproductive care centers, hospitals & clinics, home users, dentistry, and others.

Regional Analysis

The global hospital beds manufacturers is regionally segmented into the following key regions: North America, Asia Pacific, Europe, and the Middle East & Africa.

The European region held the largest share of the global automated hospital beds market as per the last research conducted in 2016. The valuation of the region stood at USD 177.5 million back then. The market standing of Europe can be attributed to factors such as high healthcare expenditure, well-established infrastructure in healthcare, and the active presence of leading players.

The North American region held the second-largest share in the global automated hospital beds market. The market is expected to grow in significant fashion during the assessment period as per the recent report published by MFRF. The growth of the region can be attributed to the well-established healthcare industry and a growing investment towards improving the infrastructure of hospitals. Add to this, continuous encouragement and support from the government to improve the hospital infrastructure in this region is a positive sign that is expected to boost the growth of the market.

Asia Pacific is another essential region in the global standings. The region is expected to garner increasing growth due to the rising number of research and development institutes, growing demand for cost-effective automated hospital beds, and an increasing number of hospitals in this region.

Finally, the Middle East & Africa region is anticipated to show steady and decent growth in the forthcoming years unlike the other booming regions mentioned above. The region is driven by the less availability of innovative healthcare technologies and lack of availability of innovative healthcare technologies.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013